CONDUIT PHARMACEUTICALS INC. Annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure from 2021 to 2023

Taxonomy & unit
us-gaap: pure
Description
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
Summary
Conduit Pharmaceuticals Inc. annual/quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate from 2021 to 2023.
  • Conduit Pharmaceuticals Inc. Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending September 30, 2022 was 0.43 pure.
  • Conduit Pharmaceuticals Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2023 was 0.21 pure, unchanged from 2022.
  • Conduit Pharmaceuticals Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2022 was 0.21 pure, unchanged from 2021.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Annual (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 0.21 0 0% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 0.21 0 0% Jan 1, 2022 Dec 31, 2022 10-Q 2023-08-14
2021 0.21 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.